Cingulate inc stock
Web20 hours ago · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. … WebAegis Capital Corp. acted as Lead Bookrunning Manager on a $25 Million Initial Public Offering of Common Stock for Cingulate Inc. (NASDAQ: CING) ACCESSWIRE-5.40%. …
Cingulate inc stock
Did you know?
WebCingulate Inc. ( CING), is a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing … WebHeadquarters. Kansas City. Employees. 15. Founded. 2013. Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery …
WebFeb 24, 2024 · The stock of Cingulate Inc. (CING) has gone down by -4.30% for the week, with a 9.90% rise in the past month and a 60.40% rise in the past quarter. The volatility ratio for the week is 8.05%, and the volatility levels for the past 30 days are 7.48% for CING. WebApr 13, 2024 · Compare with up to 5 Stocks. On Friday 02/17/2024 the closing price of the Cingulate Inc Registered Shs share was $1.07 on NAS. Compared to the opening price on …
WebApr 10, 2024 · Get Cingulate Inc (CING:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebFeb 24, 2024 · Cingulate ( CING) stock is rising higher on positive ADHD treatment news. The company’s lead candidate, CTx-1301, can apparently be taken with or without food. …
WebCingulate upsized its IPO at pricing on Dec. 7, 2024, to 4.17 million shares, up from 3.57 million in the prospectus, and warrants to buy 4.17 million shares of common stock – and priced the IPO at $6 – the low end of its $6-to-$8 range. The IPO raised $25.02 million. The stock is expected to trade under the symbol “CING” and the ...
WebApr 3, 2024 · Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of central nervous system and neurobiological disorders. The company's lead product candidates are CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine) for the treatment of attention … phonearena twitterWebApr 14, 2024 · Kate Middleton and Prince William are "very excited and delighted" that Prince George will serve as a page, a spokesperson tells PEOPLE Prince George's special role at his grandfather King Charles' coronation will be a historic first. Buckingham Palace announced last week that Prince William and ... how do you spell resubmitWebAbout Cingulate®. Cingulate® (CTx®)is a Phase 3 clinical stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery … how do you spell restaurant in frenchWebApr 7, 2024 · Cingulate Inc Stock: Bottom Line. You can use the information about how Cingulate Inc stock is graded to determine if you should invest in this specific company. … how do you spell respawnWebSouth Infirmary Victoria University Hospital. Nov 2015 - Aug 201610 months. Cork, Ireland. Perform numerous administrative tasks, as well as dealing with patients in the department. Main duties include cleaning equipment, inputting statistics on the computer, organizing stock for the everyday running of the department, managing the ... how do you spell respiratory infectionWebApr 14, 2024 · KANSAS CITY, Kan., April 14, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed … phonearkWebFind the latest Cingulate Inc. (CING) stock quote, history, news and other vital information to help you with your stock trading and investing. phonearena tmobile news